Pulse nav.journalClub ट्रेंडिंग एक्सप्लोर प्रश्न शोधकर्ता

Download the App

Join discussions, follow papers, and never miss your next session.

© Synapse Social LLC, 2026गोपनीयता नीति

होम एक्सप्लोर nav.journalClub ट्रेंडिंग

⌘+K

November 15, 2023

As Semaglutide’s Popularity Soars, Rare but Serious Adverse Effects Are Emerging

Key Points

Key points are not available for this paper at this time.

Abstract

This Medical News article discusses Wegovy, Ozempic, and other GLP-1 receptor agonists used for weight management and type 2 diabetes.

Like

Bookmark

Share

Cite This Study

Kate Ruder (Wed,) studied this question.

synapsesocial.com/papers/6a0a15e2a9b588564434beec https://doi.org/https://doi.org/10.1001/jama.2023.16620

Like

Bookmark

Share

As Semaglutide’s Popularity Soars, Rare but Serious Adverse Effects Are Emerging | Synapse